throbber
23318002
`Whatisin this leaflet:
`Contact lens wearers
`If you have suffered or are
`2.WHATYOU NEED TO
`release the lowereyelid.
`Importantinformation about
`1.What MONOPOSTis and what
`If you use MONOPOST with other
`KNOW BEFORE YOU USE
`someofthe ingredients of
`If you wear contact lenses, you
`currently suffering fromaviral
`Monopost
`MONOPOST
`it is used for
`should remove them before
`.
`eye drops
`infection of the eye caused by
`| Wait at least 5 minutes between
`MONOPOSTcontains
`the herpes simplex virus (HSV).
`2.Whatyou need to know before
`using MONOPOST.After using
`50 micrograms/ml
`‘using MONOPOSTand using
`you use MONOPOST
`Children
`macrogolglycerol hydroxystearate
`MONOPOSTyoushould wait
`eye drops,
`3.How to use MONOPOST
`‘othereye drops.
`(derived from castoroil) which
`MONOPOST hasnot been
`15 minutes before putting your
`solution in single-dose container
`4,Possible side effects
`contact lenses backin.
`may causeskin reactions.
`:
`If you use more MONOPOST
`investigatedin children (below
`5.How to store MONOPOST
`Instructions for use
`,
`than you should
`18 years).
`3.HOW TO USE MONOPOST
`6.Contents of the pack and other
`‘If you put too many drops into
`Other medicines and
`The drops are supplied in
`information
`Usual dose
`‘your eye, you may have some
`MONOPOST
`single-dose units. Use the
`: minorirritation in your eye and
`* Always use MONOPOSTexactly
`solution from one single dose
`IHAT MONOPOS:
`MONOPOSTmayinteract with
`unit for administration to the
`
`
`your eyes maywater andturn red.
`as your doctorhastold you.
`ae ate)s3
`other medicines. Tell your doctor
`This should pass, butif you are
`
`affected eye(s) immediately after
`5.Pressa finger against the
`Check with your doctor or
`or pharmacist if you are using,
`worried talk to your doctor.
`comerofthe affected eye by the
`MONOPOSTbelongs to a
`pharmacistif you are notsure.
`opening the container. Since
`have recently used or might use
`nose. Hold for 1 minute whilst
`The usual dose for adults
`sterility cannot be maintained
`group of medicines known as
`Contact your doctor as soon
`any other medicines.
`keeping the eye closed.
`after opening, throw away the
`prostaglandins.It lowers the
`(including the elderly) is one
`as possible if you swallow
`Pregnancy and breast-feeding
`containerimmediately after using
`pressure within your eye by
`drop oncea dayin the affected
`MONOPOSTaccidentally.
`Do not use MONOPOSTwhen
`the solution. Open a new single-
`increasing the natural outflow of
`eye(s). The besttime to dothis
`
`you are pregnantor breast-
`dose unit each time you use
`fluid from inside the eye into the
`is in the evening.
`If you forget to use MONOPOST
`7}
`Do not use MONOPOSTmore
`MONOPOST.
`feeding.
`bloodstream.
`: Carry on with the usual dosage
`*
`at the usualtime. Do nottake a
`If you are pregnantor breast-
`Theseinstructionstell you how to
`MONOPOSTis usedto treat
`than once a day, because the
`: double dose to makeup for a
`feeding, think you may be
`effectivenessof the treatment
`use the drops:
`conditions known as open
`‘
`forgotten dose.If you are unsure
`pregnantorare planning to
`can be reducedif you
`1. Washyour handsandsit or
`angle glaucoma and ocular
`have a baby,ask your doctor or
`administerit more often.
`‘aboutanything talk to your doctor
`hypertension. Both of these
`stand comfortably.
`+ or pharmacist.
`pharmacistfor advice before using
`conditionsarelinked with an
`* Always use MONOPOSTexactly
`this medicine.
`2. Use yourfingerto gently pull
`asthis leaflet tells you or as
`‘
`Ifyou stop using MONOPOST
`increase in the pressure within
`down the lowereyelid of your
`* Talk to your doctorif you want to
`Driving and using machines
`your doctorhastold you, until
`youreye, eventually affecting your
`affected eye.
`stop using MONOPOST.
`When you use MONOPOSTyou
`yourdoctortells you to stop.
`6. Repeatin yourothereyeif your
`eye sight.
`3.Placethetip ofthe single-
`might have blurredvision,for a
`Check with your doctor, or
`If you have any further questions
`dose containerclose to, but not
`doctor has told you to dothis.
`short time.If this happensto you,
`pharmacist or nurse if you are
`onthe useof this medicine, ask
`7. Throw away the single-dose
`touching youreye.
`not sure.
`do notdrive or use anytools
`yourdoctor, or pharmacist or
`containerafter use. Do notkeepit
`4. Squeezethe single-dose
`nurse.
`or machines until yourvision
`to useit again.
`container gently so that only one
`becomesclear again.
`drop goesinto youreye, then
`
`
`
`Latanoprost Readallof this leaflet
`
`carefully before you start
`using this medicine because
`it contains important
`information for you.
`- Keepthisleaflet. You may
`needto readit again.
`If you have any further
`questions, ask your doctor, or
`pharmacist or nurse.
`This medicine has been
`prescribed for you only. Do
`Notpassit on to others. It
`may harm them, evenif their
`signsofillness are the same
`as yours.
`If you get anyside effects,talk
`to your doctor, or pharmacist
`or nurse. This includes any
`Possible side effects notlisted
`in this leaflet. See Section 4.
`

`
`
`
`23315602
`
`AND
`
`MONOPOST Do not use MONOPOST
`
`* Ifyou areallergic
`(hypersensitive) to latanoprost
`or anyofthe otheringredients
`ofthis medicine (listed in
`section 6).
`+
`If you are pregnantortrying to
`becomepregnant.
`+
`If you are breast feeding.
`Warnings and precautions
`Talk to your doctor, or
`pharmacist or nurse before using
`MONOPOSTif you think any of
`thefollowing apply to you:
`If you are about to have or
`have had eye surgery (including
`cataract surgery).
`If you suffer from eye problems
`(such aseyepain,irritation or
`inflammation,blurred vision).
`If you know that you suffer from
`dry eyes.
`If you have severe asthma
`or your asthmais not well
`controlled.
`If you wearcontact lenses. You
`canstill use MONOPOST, but
`follow theinstruction for contact
`lens wearers in Section 3.
`
`000001
`
`Exhibit 1046
`Exhibit 1046
`ARGENTUM
`ARGENTUM
`IPR2017-01053
`IPR2017-01053
`
`000001
`
`

`

`6.CONTENTS OF THE
`PACK AND OTHER
`
`eile] What MONOPOSTcontains
`
`Theactive substance is
`latanoprost.
`1 mleye dropssolution contains
`50 microgramsoflatanoprost.
`The otheringredients are:
`macrogolglycerol hydroxystearate
`AO,sorbitol, carbomer 974P,
`macrogol 4000,disodium
`edetate, sodium hydroxide
`(for pH-adjustment), water for
`injections.
`What MONOPOSTlooks like
`and contentsof the pack
`This medicine is an eye drops,
`solution in a single-dose
`container. The solution looks
`slightly yellow and cloudy.It
`contains nopreservative,
`The single-dose containers are
`packed in a sachetof 5 units,
`eachsingle-dose container
`holding 0.2 mlof solution.
`A packsize contains 5 (1 sachet
`of 5), 10 (2 sachets of 5), 30 (6
`sachets of 5) or 90 (18 sachets
`of5) single-dose containers.
`Notall pack sizes may be
`available.
`
`Marketing Authorisation Holder
`and Manufacturer
`Marketing Authorisation Holder
`LABORATOIRES THEA
`12, RUE LOUIS BLERIOT
`63017 CLERMONT-FERRAND
`CEDEX 2
`FRANCE
`Manufacturer
`EXCELVISION
`27, RUE DE LA LOMBARDIERE
`ZI LA LOMBARDIERE
`07100 ANNONAY
`FRANCE
`This leaflet waslast revised in
`07/2014.
`
`23318002
`
`23315602
`
`N2345U30ASP/1014
`
`Othéa
`
`® H
`
`OW TO STORE
`MONOPOST
`Keep this medicine outof the
`sight and reachofchildren.
`Do notuse this medicine after
`the expiry date whichis stated on
`the carton, sachet and single-dose
`container. The expiry date refers
`to the last day of that month.
`Store below 25°C.
`Afterfirst opening of the sachet:
`use the single-dose containers
`within 7 days.
`After first opening of the single-
`dosecontainer, use immediately
`and throw awaythe single-dose
`containerafter use.
`Donot throw away any medicines
`via wastewater or household
`waste. Ask your pharmacist how
`to throw away medicines you no
`longer use. These measureswill
`help to protect the environment.
`
`Patients have also reported the
`following side-effects: fluid filled
`area within the coloured part
`ofthe eye(iris cyst), headache,
`dizziness, palpitations, muscle
`pain,joint pain and developing a
`viral infection of the eye caused
`by the herpes simplex virus
`(HSV).
`Reportingof side effects
`If you get anyside effects,talk
`to your doctor, or pharmacist or
`nurse. This includes any possible
`side effects notlisted in this
`leaflet.
`You can also report side effects
`directly via the Yellow Card
`Scheme.
`Website:
`www.mhra.gov.uk/yellowcard
`Byreporting side effects you can
`help provide more information on
`the safety of this medicine.
`
`4.POSSIBLE SIDE EFFECTS
`Like all medicines, this medicine
`can causeside effects, although
`not everybody gets them.
`Very common:mayaffect more
`than 1 in 10 people
`+ A gradual change in your eye
`colourbyincreasing the amount
`of brown pigmentin the
`coloured part of the eye known
`astheiris.
`-
`Ifyou have mixed-colour eyes
`(blue-brown,grey-brown,
`yellow-brown orgreen-
`brown)you are morelikely
`to see this change thanif
`you have eyesof one colour
`(blue, grey, green or brown
`eyes).
`Any changesin your eye
`colour may take years
`to developalthoughit
`is normally seen within
`8 monthsoftreatment.
`- The colour change may be
`permanent and may be
`morenoticeable if you use
`MONOPOSTin only oneeye.
`There appears to be no
`problemsassociated with the
`changein eye colour.
`
`- The eye colour change
`doesnot continue after
`MONOPOSTtreatmentis
`stopped.
`Rednessof the eye.
`+ Eyeirritation (a feeling of
`burning, grittiness, itching,
`stinging or the sensation of a
`foreign bodyin the eye).
`+ A gradual change to eyelashes
`ofthe treated eye and the
`fine hairs around the treated
`eye, seen mostly in people
`of Japaneseorigin. These
`changesinvolve an increase of
`the colour (darkening), length,
`thickness and numberof your
`eyelashes.
`Common:mayaffect up to 1
`in
`10 people
`*
`Irritation or disruption to the
`surface ofthe eye, eyelid
`inflammation (blepharitis) and
`eye pain.
`Uncommon:mayaffect up to 1
`in 100 people
`+ Eyelid swelling, dryness of the
`eye,inflammationorirritation
`of the surface of the eye
`(keratitis), blurred vision and
`conjunctivitis.
`Skin rash.
`
`Rare: mayaffect up to 1 in
`1,000 people
`Inflammationof theiris, the
`coloured part of the eye
`(iritis/uveitis), swelling of the
`retina (macular oedema),
`symptoms of swelling or
`scratching/damageto the
`surface of the eye, swelling
`aroundthe eye (periorbital
`oedema) misdirected
`eyelashes oran extra row of
`eyelashes, sensitivity to light
`(photophobia).
`Skin reactions on the eyelids,
`darkening of the skin of the
`eyelids.
`Asthma, worsening of asthma
`and shortness of breath
`(dyspnoea).
`Very rare: mayaffect up to 1 in
`10,000 people
`whoalso have heart disease.
`+ Worseningof angina in patients
`* Chestpain.
`+ Sunken eye appearance (eye
`sulcus deepening).
`
`000002
`
`000002
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket